Cerebral amyloid in human prion disease

Area of Science:

• Neuropathology
• Genetics
• Neurodegenerative Diseases

Background:

• Prion diseases encompass a spectrum of neurodegenerative disorders.
• Cerebral amyloid deposition is a hallmark in various prion proteinopathies.
• Understanding the interplay between prion protein gene mutations and amyloid pathology is crucial.

Purpose of the Study:

• To investigate the clinical and neuropathological features of prion diseases.
• To examine the morphology and immunoreactivity of cerebral amyloid in relation to prion protein (PrP) gene mutations.
• To elucidate the association between prion disease and amyloid deposition.

Main Methods:

• Review of clinical and neuropathological data from 21 patients with prion disease.
• Analysis of prion protein (PrP) gene mutations, including codon 102 and 216 base-pair insertions.
• Immunohistochemical staining for PrP and beta-protein in cerebral amyloid deposits.

Main Results:

• Six cases with PrP gene codon 102 mutation showed multicentric amyloid plaques with PrP staining; spongiform changes were minimal or absent.
• A case with a PrP gene 216 base-pair insertion exhibited prominent cerebellar amyloid without spongiform encephalopathy (SE).
• Amyloid deposition, including amyloid angiopathy and senile plaques, was observed in familial and sporadic prion diseases, with PrP found in plaques in a high proportion of inherited cases.

Conclusions:

• Prion diseases are significantly associated with amyloid deposition in the brain.
• Prion protein (PrP) is a component of amyloid plaques in many prion disease cases, including sporadic forms.
• The findings emphasize the complex relationship between genetic mutations, prion protein, and amyloid pathology in neurodegeneration.